Return-path: <bounce-18416124_HTML-982008319-36131896-10831468-449@bounce.broadcastemail.asco.org>
Envelope-to: info@seeinindia.com
Delivery-date: Mon, 01 Jun 2015 14:18:38 +0000
Received: from mta.broadcastemail.asco.org ([64.132.92.206]:33205)
	by bh-in-11.webhostbox.net with esmtp (Exim 4.85)
	(envelope-from <bounce-18416124_HTML-982008319-36131896-10831468-449@bounce.broadcastemail.asco.org>)
	id 1YzQY0-004Hei-O9
	for info@seeinindia.com; Mon, 01 Jun 2015 14:18:38 +0000
Received: by mta.broadcastemail.asco.org id hdhkro163hsj for <info@seeinindia.com>; Mon, 1 Jun 2015 08:18:26 -0600 (envelope-from <bounce-18416124_HTML-982008319-36131896-10831468-449@bounce.broadcastemail.asco.org>)
From: "Daily News" <dailynews@asco.org>
To: <info@seeinindia.com>
Subject: Plenary: Effective Combination for Advanced Melanoma, Improved Survival in Early Oral Cancers, and More
Date: Mon, 01 Jun 2015 08:18:26 -0600
List-Unsubscribe: <mailto:leave-fc5015787165027c77101f2d205921-fe271d7877640475761579-fe5a1776746705757c12-fe6015707d670579731c-ff5e10747c@leave.broadcastemail.asco.org>
MIME-Version: 1.0
x-job: 10831468_36131896
Message-ID: <5c6f8af6-324d-4f47-8adc-04376c8695b8@xtinmta06.xt.local>
Content-Type: multipart/alternative;
	boundary="gsbCJixYb5BE=_?:"
X-Authenticated_sender: 

This is a multi-part message in MIME format.

--gsbCJixYb5BE=_?:
Content-Type: text/plain;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit

To view this email as a web page, go to the link below, or copy and paste it into your browser's address window.
http://click.broadcastemail.asco.org/?qs=babd0227a5dd2adbc8705cc2da5715041373c1cb08abc6b1f7fecd89f2509e9a076cab160036ff15ASCO
http://click.broadcastemail.asco.org/?qs=babd0227a5dd2adbef316d681bff984954742c42466f604d206e8829d19c9ef1e6fd9a734e628a09 

Advertisement


 

http://click.broadcastemail.asco.org/?qs=babd0227a5dd2adb64ae913d1b005c6a45e284cec5fd7d00cecc0adfec09028d3e7c72e42391b34f 


ASCO's 2015 Plenary Presentations


http://click.broadcastemail.asco.org/?qs=babd0227a5dd2adbdfae4ef024d50b052ae6beaa9cc47ae304ebab321214b4547358ba404db13ee5 
Abstract LBA1: 
Nivolumab, Ipilimumab Combination Effective in Advanced Melanoma; Cost Questions Raised
 

http://click.broadcastemail.asco.org/?qs=babd0227a5dd2adb6314c69e7a88d511ed72ec787de91a50dc48fb085da824f49d72447f7698def5 


Abstract LBA2: Changes in Pediatric Cancer Treatments Yield Reduced Late Mortality

http://click.broadcastemail.asco.org/?qs=babd0227a5dd2adb0c1cbfee8a8caed8b57a1b6ce4d20367745d70af81f1412f7f009656299d14b2 


Abstract LBA3: Elective Neck Dissection Improves Survival in Early Oral Cancers 

http://click.broadcastemail.asco.org/?qs=babd0227a5dd2adb60c06fd3e0da31add500f222c3fa113eac9d0505b9f5a947a5a926cc4228cb72 


Abstract LBA4: In Brain Metastases, Adding WBRT to SRS Improves Local Control but Not Survival

 

http://click.broadcastemail.asco.org/?qs=babd0227a5dd2adbb234f777ebaa8878856ffac9399af2ad1e6344030fa4e2b284afaabed2d580cf 
Docetaxel with Traditional Treatments Improves Outcomes of Advanced, Localized Prostate Cancer 

http://click.broadcastemail.asco.org/?qs=babd0227a5dd2adbb234f777ebaa8878856ffac9399af2ad1e6344030fa4e2b284afaabed2d580cf 
 
Two abstracts presented during the Genitourinary (Prostate) Cancer Oral Abstract Session showed significantly improved overall survival when docetaxel was added to standard hormone therapy in patients with advanced, hormone-naive prostate cancer (Abstract 5001) and hormone therapy plus radiation therapy in men with high-risk localized prostate cancer (Abstract LBA5002). 


http://click.broadcastemail.asco.org/?qs=babd0227a5dd2adbb234f777ebaa8878856ffac9399af2ad1e6344030fa4e2b284afaabed2d580cf 
Read the Full Story » 

 

http://click.broadcastemail.asco.org/?qs=5169be9a213a05d57e936dfddd3b499bd2452a1af76e08059e48145acf5367af26b17bb673f8d28b 
 
http://click.broadcastemail.asco.org/?qs=5169be9a213a05d57e936dfddd3b499bd2452a1af76e08059e48145acf5367af26b17bb673f8d28b 

Malignant Pleural Mesothelioma: IFCT-GFPC-0701 MAPS Phase III Trial Results
 

Dr. Gerard Zalcman (pictured) presented the results of the phase III IFCT-GFPC-0701 MAPS trial, which examined whether the addition of bevacizumab to standard chemotherapy would affect overall survival in patients with malignant pleural mesothelioma (Abstract 7500).


http://click.broadcastemail.asco.org/?qs=5169be9a213a05d57e936dfddd3b499bd2452a1af76e08059e48145acf5367af26b17bb673f8d28b 
Read the Full Story » 

 

http://click.broadcastemail.asco.org/?qs=5169be9a213a05d5a431d86ff98b70b14dc1491c2fb0c937f7569111e6efd8e7d935aafaf4b4be29 

Cost of Cancer Drugs Should Be Part of Treatment Decisions
 

http://click.broadcastemail.asco.org/?qs=5169be9a213a05d5a431d86ff98b70b14dc1491c2fb0c937f7569111e6efd8e7d935aafaf4b4be29 
 
The Health Services Research and Quality of Care Oral Abstract Session focused on how cost does not always reflect drug value, efforts to consider cost as part of treatment decisions, and methods to set new drug prices based on value. Dr. Peter B. Bach (pictured) asked, "Why treat prices as immutable? Would we really pay an infinite amount for a microscopic benefit?" 


http://click.broadcastemail.asco.org/?qs=5169be9a213a05d5a431d86ff98b70b14dc1491c2fb0c937f7569111e6efd8e7d935aafaf4b4be29 
Read the Full Story » 

 

http://click.broadcastemail.asco.org/?qs=5169be9a213a05d5c6f969d990d48b34c808c94d8e70ca8229b11df9b857b38c998f773a08081b13 
 
http://click.broadcastemail.asco.org/?qs=5169be9a213a05d5c6f969d990d48b34c808c94d8e70ca8229b11df9b857b38c998f773a08081b13 
Dr. Ernest Hawk Named the 2015 ASCO-ACS Award Recipient for Significant Contributions to Cancer Prevention 

Dr. Ernest Hawk's (pictured) efforts in research, education, and promotion of cancer prevention lead him to be named the 2015 ASCO-American Cancer Society Award recipient.


http://click.broadcastemail.asco.org/?qs=5169be9a213a05d5c6f969d990d48b34c808c94d8e70ca8229b11df9b857b38c998f773a08081b13 
Read the Full Story » 

 

http://click.broadcastemail.asco.org/?qs=5169be9a213a05d5da5528937daadbb852b9c80b1a23d9da022becbb36d5830e4537ebbb4f832f0e 

http://click.broadcastemail.asco.org/?qs=5169be9a213a05d5da5528937daadbb852b9c80b1a23d9da022becbb36d5830e4537ebbb4f832f0e 

Communicating Genetic Test Results to Patients and Their Families
 

Wendy Kohlmann, Marjan Champine, and Dr. Sarah Colonna (left to right) present their thoughts on discussing genetic testing with patients and their families, including obtaining informed consent, explaining mutations, and recommending genetic counseling.


http://click.broadcastemail.asco.org/?qs=5169be9a213a05d5da5528937daadbb852b9c80b1a23d9da022becbb36d5830e4537ebbb4f832f0e 
Read the Full Story » 

 
http://click.broadcastemail.asco.org/?qs=5169be9a213a05d597dcd3ffdbf8a31e9a7663a807c098aa80a048b0425b5480612ae8532d969715 

http://click.broadcastemail.asco.org/?qs=5169be9a213a05d597dcd3ffdbf8a31e9a7663a807c098aa80a048b0425b5480612ae8532d969715 

Exercise Alterations of the Host-Tumor Interaction
 

In this Expert Editorial, Dr. Lee W. Jones (pictured), examines if higher levels of exercise following diagnosis could be associated with improvements in cancer outcomes in patients with operable breast, prostate, and colorectal cancers.

http://click.broadcastemail.asco.org/?qs=5169be9a213a05d597dcd3ffdbf8a31e9a7663a807c098aa80a048b0425b5480612ae8532d969715 
Read the Full Story » 

http://click.broadcastemail.asco.org/?qs=5169be9a213a05d5563d848331c20f59fc4ef6af2fde35e883c7aecd0111dc4bf70b99d076030cd9 
ASCO Daily News Home
http://click.broadcastemail.asco.org/?qs=5169be9a213a05d5abff5b68d464da8919f533ad40e8ce2d16d0fa39799d1bf880814013a32fa021 
 | 
http://click.broadcastemail.asco.org/?qs=5169be9a213a05d543b074bba612b5bfcd0924004f1e0efe76ca403b5973bdd87730a273ada64452 
Session Coverage  | 
http://click.broadcastemail.asco.org/?qs=5169be9a213a05d577db732cc556b1060b3a635f796658b94de2b98f4ae6054e75b0156da8fbe4d4 
Expert Editorials 

http://click.broadcastemail.asco.org/?qs=5169be9a213a05d536f1a350988f4adeaae0c53bacbfe9bd0899098ae7d3f88d6c2d89fcc5623051 
Grants and Awards  | 
http://click.broadcastemail.asco.org/?qs=19f93dd33476a1551b116ebd2b426642d787ee2ae2c90bc5aa8aab3cc808ccada04c3d13968f8439 
am.asco.org 

Connect with us:
http://click.broadcastemail.asco.org/?qs=19f93dd33476a1559b4c7ce08e8343202460711badb543a61a344da74243424aa1c562f1e3d29cd9 

http://click.broadcastemail.asco.org/?qs=19f93dd33476a155972bf0b07d01bc94a72f754afbf64ff866550d2ca0fdbf3914210c1f23fb5c58 

http://click.broadcastemail.asco.org/?qs=19f93dd33476a155709e0957d1d7079fe075544c909a0de5e541636e8431646543cbb1da2aabc53a 

http://click.broadcastemail.asco.org/?qs=19f93dd33476a155c7e4af5b1531deed4fd88932038a5fe57775063e800a0a1634fa87cfb248c5af 
Forward to a Colleague 
http://click.broadcastemail.asco.org/?qs=19f93dd33476a155c7e4af5b1531deed4fd88932038a5fe57775063e800a0a1634fa87cfb248c5af 

 
http://click.broadcastemail.asco.org/?qs=19f93dd33476a1559a6cb06291b7c17febbde0a483b63d8a31ab31ec951bd1dd4ee03cb673664eae 

Advertisement

http://click.broadcastemail.asco.org/?qs=19f93dd33476a155eb456b80ed95511dbd526cb2267e6c8280acc324f7c38ca9ae1de54cb9ef1087 

Advertisement








You are receiving this email because you have an existing relationship
with ASCO.  Visit your personalized 
http://click.broadcastemail.asco.org/?qs=19f93dd33476a155cef565b81034df41edd95557398b1eb0f6746ebf0cccd79fb0b6c35f5d3a9372 
Preference Center  to unsubscribe or to select
your preferences for receiving ASCO promotional email.  Please do
not reply to this email.  

This email was sent by: American Society of Clinical Oncology

2318 Mill Road, Suite 800 Alexandria, VA,
22314, USA



--gsbCJixYb5BE=_?:
Content-Type: text/html;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<div style="display:block;width:100%;text-align:center;font-family: Verdana, sans-serif;font-size:10px;color:#444444;padding:8px 0;margin:auto;">
	To view this email as a web page, go   <a href="http://click.broadcastemail.asco.org/?qs=82ae44964bd2fbd21fd4b7e002acaafd54728c87d7eb5fc983eb6849943d31f0c40fb996b00fdc37" > here</a>.
</div><!DOCTYPE html>
<html lang="en">

<head>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <title>ASCO</title>

    <style>
        
        body {margin:0; padding:0; -webkit-text-size-adjust:none; -ms-text-size-adjust:none;} img{line-height:100%; outline:none; text-decoration:none; -ms-interpolation-mode: bicubic;} a img{border: none;} #backgroundTable {margin:0; padding:0; width:100% !important; } a, a:link{color:#318786; text-decoration: none;} table td {border-collapse:collapse;} span {color: inherit; border-bottom: none;} span:hover { background-color: transparent; }

    </style>
</head><body style="background: #d8d8d8;font-family:Arial, Helvetica, sans-serif; font-size:1em;">


    <table id="backgroundTable" width="100%" cellspacing="0" cellpadding="0" border="0" style="background:#d8d8d8;">
        <tr>
            <td class="body" align="center" valign="top" style="background:#d8d8d8;" width="100%">
                <table cellpadding="0" cellspacing="0">
                    <tr>
                        <td class="banner" width="826" align="center" style="background: #d8d8d8; padding-top: 16px;">
                            <table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><div align="center">
<a href="http://click.broadcastemail.asco.org/?qs=82ae44964bd2fbd230a5b59696de2c35093ae73b1a59a3152b41dac943dcb648a24914cd12c09214" title="Banner Ad"  ><img width="728" height="90" border="0" alt="Monday_728x90" title="Monday_728x90" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/1-alectinib_alex_unbranded_banner_728x90.gif" style="width: 728px; height: 90px; border-color: #000000; margin: 0px;" /></a><br />Advertisement
</div></td></tr></table></td></tr></table>&nbsp;
                        </td>
                    </tr>
                    <tr>
                       
                    </tr>
                    <tr>
                        <td class="main" width="826" align="center">
                            <table cellpadding="0" cellspacing="0">
	<tr>
        <td class="header" width="826" align="left">
            
        </td>
    </tr>
    <tr>
    	<td class="subheader" width="826" align="left">
    		<table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><a href="http://click.broadcastemail.asco.org/?qs=82ae44964bd2fbd22f3185fa79aa0d36f8ae49023bd3b1b04dc7b52e41bae07bdf3c6e043744db8e" title="AM2015 Daily News"  ><img width="826" height="115" border="0" alt="AM15daily-banner-826x115-eDigest" title="AM15daily-banner-826x115-eDigest" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/AM15daily-banner-826x115-eDigest.png" style="width: 826px; height: 115px; border-color: #000000; margin: 0px;" /></a></td></tr></table></td></tr></table>
    	</td>
    </tr>
    <tr>
    	<td width="826" style="background: #d8d8d8;">
    		<table cellpadding="0" cellspacing="0">
    			<tr>
    				<td style="padding: 16px;">
    					<table cellpadding="0" cellspacing="0">
    						<tr>
    							<td width="618" valign="top">
    								<table cellpadding="0" cellspacing="0">
    									<tr>
    										<td width="618"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table cellspacing="0" cellpadding="0" class="dashedBorder">
	<tbody>
		<tr>
			<td width="618" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
			<img width="618" height="254" mdid="d95eb8bb-f0a3-4cb2-8285-16c97c42f784" title="OO.LBA1.Brief_Crowd3" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/OO.LBA1.Brief_Crowd3.jpg" alt="OO.LBA1.Brief_Crowd3" style="display: block; border: 0px none; width: 618px; height: 254px; margin: 0px;" />
			</td>
		</tr>
		<tr>
			<td width="618" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
			<table cellspacing="0" cellpadding="0">
				<tbody>
					<tr>
						<td style="padding: 20px 24px;">
						<table cellspacing="0" cellpadding="0">
							<tbody>
								<tr>
									<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786; padding-bottom: 12px;">
									ASCO's 2015 Plenary Presentations
									</td>
								</tr>
								<tr>
									<td align="left" style="font-family: arial,sans-serif; font-size: 14px; color: #747474; padding-bottom: 16px; line-height: 18px ! important;">
									<ul>
									</ul>
									<a   href="http://click.broadcastemail.asco.org/?qs=82ae44964bd2fbd245de92d8ca53970bf4250da6df7c89e547403cc4aa98b3340a58926c2f13060c" title=" ASCO Plenary Briefing: Nivolumab, Ipilimumab Combination Effective in Advanced Melanoma" style="color: #318786; text-decoration: none;">Abstract LBA1: 
Nivolumab, Ipilimumab Combination Effective in Advanced Melanoma; Cost Questions Raised
</a><br />
									<a   href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599ac4eb51987ae5d47d2e403deef6a4ce334500326591625b1765b486dcdb30d352f" title=" ASCO Plenary Briefing: Changes in Pediatric Cancer Treatments Yield Reduced Late Mortality" style="color: #318786; text-decoration: none;"><br />
									Abstract LBA2: Changes in Pediatric Cancer Treatments Yield Reduced Late Mortality</a><br />
									<a   href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599ac8fc645059673007ed5b6e211699199ef719d7455f9d1099cadb8e78ffb91c0e1" title=" ASCO Plenary Briefing: Elective Neck Dissection Improves Survival in Early Oral Cancers" style="color: #318786; text-decoration: none;"><br />
									Abstract LBA3: Elective Neck Dissection Improves Survival in Early Oral Cancers </a><br />
									<a   href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599acfaa8ed36dc7712b246520d86a36020d4fbd82b2bd2a1b32c70cf60b6a9320cfe" title=" ASCO Plenary Briefing: In Brain Metastases, Adding WBRT to SRS Improves Local Control but Not Survival" style="color: #318786; text-decoration: none;"><br />
									Abstract LBA4: In Brain Metastases, Adding WBRT to SRS Improves Local Control but Not Survival</a>
									</td>
								</tr>
							</tbody>
						</table>
						</td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
		<tr>
			<td width="618" height="16" style="font-size: 1px;">&nbsp;</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
    									</tr>
    									<tr>
    										<td width="618"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table cellspacing="0" cellpadding="0" class="dashedBorder">
	<tbody>
		<tr>
			<td width="618" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
			<table cellspacing="0" cellpadding="0">
				<tbody>
					<tr>
						<td style="padding: 20px 24px;">
						<table cellspacing="0" cellpadding="0">
							<tbody>
								<tr>
									<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786; padding-bottom: 12px;">
									<a   title=" Docetaxel with Traditional Treatments Improves Outcomes of Advanced, Localized Prostate Cancer" href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599ac8cfb1ff72669cafccb42e099a72aba1a37c310f7accf6c05dd741cadaf8df20b" style="text-decoration: none; color: #318786;">Docetaxel with Traditional Treatments Improves Outcomes of Advanced, Localized Prostate Cancer</a>
									</td>
								</tr>
								<tr>
									<td width="570" align="left">
									<table cellspacing="0" cellpadding="0">
										<tbody>
											<tr>
												<td width="284" valign="top">
												<a   title=" Docetaxel with Traditional Treatments Improves Outcomes of Advanced, Localized Prostate Cancer" href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599ac8cfb1ff72669cafccb42e099a72aba1a37c310f7accf6c05dd741cadaf8df20b"><img width="284" height="148" thid="8354bde1-0fab-4077-9e1f-82e6e3a0c74e" title="5001.5002" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/5001.5002.jpg" alt="5001.5002" style="display: block; border: 0px none; width: 284px; height: 148px; margin: 0px;" /></a>
												</td>
												<td width="24" style="font-size: 1px;">&nbsp;</td>
												<td width="262" valign="top" align="left">
												<table cellspacing="0" cellpadding="0">
													<tbody>
														<tr>
															<td align="left" style="font-family: arial,sans-serif; font-size: 14px; color: #747474; padding-bottom: 16px; line-height: 18px ! important;">
Two abstracts presented during the Genitourinary (Prostate) Cancer Oral Abstract Session showed significantly improved overall survival when docetaxel was added to standard hormone therapy in patients with advanced, hormone-naive prostate cancer (Abstract 5001) and hormone therapy plus radiation therapy in men with high-risk localized prostate cancer (Abstract LBA5002). 
															</td>
														</tr>
														<tr>
															<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786;">
															<a   title=" Docetaxel with Traditional Treatments Improves Outcomes of Advanced, Localized Prostate Cancer" href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599ac8cfb1ff72669cafccb42e099a72aba1a37c310f7accf6c05dd741cadaf8df20b" style="text-decoration: none; color: #318786;">Read the Full Story &#187;</a>
															</td>
														</tr>
													</tbody>
												</table>
												</td>
											</tr>
										</tbody>
									</table>
									</td>
								</tr>
							</tbody>
						</table>
						</td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
		<tr>
			<td width="618" height="16" style="font-size: 1px;">&nbsp;</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
    									</tr>
    									<tr>
    										<td width="618"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table cellspacing="0" cellpadding="0" class="dashedBorder">
	<tbody>
		<tr>
			<td width="618" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
			<table cellspacing="0" cellpadding="0">
				<tbody>
					<tr>
						<td style="padding: 20px 24px;">
						<table cellspacing="0" cellpadding="0">
							<tbody>
								<tr>
									<td width="168" valign="top">
									<a href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599acc226afe3df25762c8793ad5404ddd24d01cda95185422fd07a1d10fe21ce3dc1" title=" Malignant Pleural Mesothelioma: IFCT-GFPC-0701 MAPS Phase III Trial Results"  ><img width="168" height="174" style="display: block; border: 0px none; width: 168px; height: 174px; margin: 0px;" alt="Mon.A.7500_Zalcman2" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/Mon.A.7500_Zalcman2.jpg" title="Mon.A.7500_Zalcman2" thid="a3e4b16d-39d5-47d1-807c-00c52c3a3660" /></a>
									</td>
									<td width="24" style="font-size: 1px;">&nbsp;</td>
									<td width="378" valign="top" align="left">
									<table cellspacing="0" cellpadding="0">
										<tbody>
											<tr>
												<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786; padding-bottom: 12px;">
												<a style="text-decoration: none; color: #318786;" href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599acc226afe3df25762c8793ad5404ddd24d01cda95185422fd07a1d10fe21ce3dc1" title=" Malignant Pleural Mesothelioma: IFCT-GFPC-0701 MAPS Phase III Trial Results"  >
Malignant Pleural Mesothelioma: IFCT-GFPC-0701 MAPS Phase III Trial Results
</a>
												</td>
											</tr>
											<tr>
												<td align="left" style="font-family: arial,sans-serif; font-size: 14px; color: #747474; padding-bottom: 16px; line-height: 18px ! important;">
												Dr. G&#233;rard Zalcman (pictured) presented the results of the phase III IFCT-GFPC-0701 MAPS trial, which examined whether the addition of bevacizumab to standard chemotherapy would affect overall survival in patients with malignant pleural mesothelioma (Abstract 7500).  
												</td>
											</tr>
											<tr>
												<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786;">
												<a style="text-decoration: none; color: #318786;" href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599acc226afe3df25762c8793ad5404ddd24d01cda95185422fd07a1d10fe21ce3dc1" title=" Malignant Pleural Mesothelioma: IFCT-GFPC-0701 MAPS Phase III Trial Results"  >Read the Full Story &#187;</a>
												</td>
											</tr>
										</tbody>
									</table>
									</td>
								</tr>
							</tbody>
						</table>
						</td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
		<tr>
			<td width="618" height="16" style="font-size: 1px;">&nbsp;</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
    									</tr>
    									<tr>
    										<td width="618"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table cellspacing="0" cellpadding="0" class="dashedBorder">
	<tbody>
		<tr>
			<td width="618" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
			<table cellspacing="0" cellpadding="0">
				<tbody>
					<tr>
						<td style="padding: 20px 24px;">
						<table cellspacing="0" cellpadding="0">
							<tbody>
								<tr>
									<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786; padding-bottom: 12px;">
									<a href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599acdddfa6cea3698327bb74c71f2c0a57cdfd81df499140ad767562e4e948307701" style="text-decoration: none; color: #318786;" title=" Cost of Cancer Drugs Should Be Part of Treatment Decisions"  >
									Cost of Cancer Drugs Should Be Part of Treatment Decisions
									</a>
									</td>
								</tr>
								<tr>
									<td width="570" align="left">
									<table cellspacing="0" cellpadding="0">
										<tbody>
											<tr>
												<td width="284" valign="top">
												<a href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599acdddfa6cea3698327bb74c71f2c0a57cdfd81df499140ad767562e4e948307701" title=" Cost of Cancer Drugs Should Be Part of Treatment Decisions"  ><img width="284" height="148" thid="8b2dea10-f85a-43d3-b049-3ddd1d78a304" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/Peter_Bach.jpg" alt="Peter_Bach" style="display: block; border: 0px none; width: 284px; height: 148px; margin: 0px;" title="Peter_Bach" /></a>
												</td>
												<td width="24" style="font-size: 1px;">&nbsp;</td>
												<td width="265" valign="top" align="left">
												<table cellspacing="0" cellpadding="0">
													<tbody>
														<tr>
															<td align="left" style="font-family: arial,sans-serif; font-size: 14px; color: #747474; padding-bottom: 16px; line-height: 18px ! important;">
															The Health Services Research and Quality of Care Oral Abstract Session focused on how cost does not always reflect drug value, efforts to consider cost as part of treatment decisions, and methods to set new drug prices based on value. Dr. Peter B. Bach (pictured) asked, &quot;Why treat prices as immutable? Would we really pay an infinite amount for a microscopic benefit?&quot; 
															</td>
														</tr>
														<tr>
															<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786;">
															<a href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599acdddfa6cea3698327bb74c71f2c0a57cdfd81df499140ad767562e4e948307701" style="text-decoration: none; color: #318786;" title=" Cost of Cancer Drugs Should Be Part of Treatment Decisions"  >Read the Full Story &#187;</a>
															</td>
														</tr>
													</tbody>
												</table>
												</td>
											</tr>
										</tbody>
									</table>
									</td>
								</tr>
							</tbody>
						</table>
						</td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
		<tr>
			<td width="618" height="16" style="font-size: 1px;">&nbsp;</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
    									</tr>
    									<tr>
    										<td width="618"></td>
    									</tr>
    									<tr>
    										<td width="618"></td>
    									</tr>
    									<tr>
    										<td width="618"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table cellspacing="0" cellpadding="0" class="dashedBorder">
	<tbody>
		<tr>
			<td width="618" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
			<table cellspacing="0" cellpadding="0">
				<tbody>
					<tr>
						<td style="padding: 20px 24px;">
						<table cellspacing="0" cellpadding="0">
							<tbody>
								<tr>
									<td width="168" valign="top">
									<a   title=" Dr. Ernest Hawk Named the 2015 ASCO-ACS Award Recipient for Significant Contributions to Cancer Prevention" href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599acf31785e0d4760af7a5f6823d47cccfa3c5213ff06fbb4218fd79254a2ceb9890"><img width="168" height="174" thid="b6127015-a1ce-41e7-a678-cdec4e6bc02c" title="AMDN15.SA.ASCO_ACSAward_Hawk_crop" style="display: block; border: 0px none; width: 168px; height: 174px; margin: 0px;" alt="AMDN15.SA.ASCO_ACSAward_Hawk_crop" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/AMDN15.SA.ASCO_ACSAward_Hawk_crop.jpg" /></a>
									</td>
									<td width="24" style="font-size: 1px;">&nbsp;</td>
									<td width="378" valign="top" align="left">
									<table cellspacing="0" cellpadding="0">
										<tbody>
											<tr>
												<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786; padding-bottom: 12px;">
												<a   title=" Dr. Ernest Hawk Named the 2015 ASCO-ACS Award Recipient for Significant Contributions to Cancer Prevention" style="text-decoration: none; color: #318786;" href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599acf31785e0d4760af7a5f6823d47cccfa3c5213ff06fbb4218fd79254a2ceb9890">Dr. Ernest Hawk Named the 2015 ASCO-ACS Award Recipient for Significant Contributions to Cancer Prevention</a>
												</td>
											</tr>
											<tr>
												<td align="left" style="font-family: arial,sans-serif; font-size: 14px; color: #747474; padding-bottom: 16px; line-height: 18px ! important;">
Dr. Ernest Hawk's (pictured) efforts in research, education, and promotion of cancer prevention lead him to be named the 2015 ASCO-American Cancer Society Award recipient.
												</td>
											</tr>
											<tr>
												<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786;">
												<a   title=" Dr. Ernest Hawk Named the 2015 ASCO-ACS Award Recipient for Significant Contributions to Cancer Prevention" style="text-decoration: none; color: #318786;" href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599acf31785e0d4760af7a5f6823d47cccfa3c5213ff06fbb4218fd79254a2ceb9890">Read the Full Story &#187;</a>
												</td>
											</tr>
										</tbody>
									</table>
									</td>
								</tr>
							</tbody>
						</table>
						</td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
		<tr>
			<td width="618" height="16" style="font-size: 1px;">&nbsp;</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
    									</tr>
									    <tr>
									    	<td width="618"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table cellspacing="0" cellpadding="0" class="dashedBorder">
	<tbody>
		<tr>
			<td width="618" style="padding-bottom: 16px;">
			<table cellspacing="0" cellpadding="0">
				<tbody>
					<tr>
						<td width="301" valign="top">
						<table cellspacing="0" cellpadding="0">
							<tbody>
								<tr>
									<td width="301" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
									<a   title=" Communicating Genetic Test Results to Patients and Their Families" href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599ac87a5edcfb03b2d61155b0cd173489a7688e74a0d42e1d38fbb0e2056bf24d911"><img width="301" height="190" thid="e6d9e13e-3aea-4ece-b2de-a4c7ed79d5c2" title="Genetic Testing Combined" style="display: block; border: 0px none; width: 301px; height: 190px; margin: 0px;" alt="Genetic Testing Combined" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/Genetic+Testing+Combined.png" /></a>
									</td>
								</tr>
								<tr>
									<td width="301" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
									<table cellspacing="0" cellpadding="0">
										<tbody>
											<tr>
												<td style="padding: 20px 24px;">
												<table cellspacing="0" cellpadding="0">
													<tbody>
														<tr>
															<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786; padding-bottom: 12px;">
															<a   title=" Communicating Genetic Test Results to Patients and Their Families" style="text-decoration: none; color: #318786;" href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599ac87a5edcfb03b2d61155b0cd173489a7688e74a0d42e1d38fbb0e2056bf24d911">
															Communicating Genetic Test Results to Patients and Their Families
															</a>
															</td>
														</tr>
														<tr>
															<td align="left" style="font-family: arial,sans-serif; font-size: 14px; color: #747474; padding-bottom: 16px; line-height: 18px ! important;">
															Wendy Kohlmann, Marjan Champine, and Dr. Sarah Colonna (left to right) present their thoughts on discussing genetic testing with patients and their families, including obtaining informed consent, explaining mutations, and recommending genetic counseling.
															</td>
														</tr>
														<tr>
															<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786;">
															<a   title=" Communicating Genetic Test Results to Patients and Their Families" style="text-decoration: none; color: #318786;" href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599ac87a5edcfb03b2d61155b0cd173489a7688e74a0d42e1d38fbb0e2056bf24d911">Read the Full Story &#187;</a>
															</td>
														</tr>
													</tbody>
												</table>
												</td>
											</tr>
										</tbody>
									</table>
									</td>
								</tr>
							</tbody>
						</table>
						</td>
						<td width="16" style="font-size: 1px;">&nbsp;</td>
						<td width="301" valign="top">
						<table cellspacing="0" cellpadding="0">
							<tbody>
								<tr>
									<td width="301" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
									<a href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599ac65579570c2fbf91be31c83cbd51ed55ff854bc6ec5fdca9c5e3647b45c67ef4c" title=" Exercise Alterations of the Host-Tumor Interaction"  ><img width="301" height="190" style="display: block; border: 0px none; width: 301px; height: 190px; margin: 0px;" alt="Jones_Lee_crop" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/Jones_Lee_crop.jpg" title="Jones_Lee_crop" thid="58198bb5-f6bb-4ecd-b528-a49a9ef55682" /></a>
									</td>
								</tr>
								<tr>
									<td width="301" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
									<table cellspacing="0" cellpadding="0">
										<tbody>
											<tr>
												<td style="padding: 20px 24px;">
												<table cellspacing="0" cellpadding="0">
													<tbody>
														<tr>
															<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786; padding-bottom: 12px;">
															<a style="text-decoration: none; color: #318786;" href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599ac65579570c2fbf91be31c83cbd51ed55ff854bc6ec5fdca9c5e3647b45c67ef4c" title=" Exercise Alterations of the Host-Tumor Interaction"  >
															Exercise Alterations of the Host-Tumor Interaction
															</a>
															</td>
														</tr>
														<tr>
															<td align="left" style="font-family: arial,sans-serif; font-size: 14px; color: #747474; padding-bottom: 16px; line-height: 18px ! important;">
															In this Expert Editorial, Dr. Lee W. Jones (pictured), examines if higher levels of exercise following diagnosis could be associated with improvements in cancer outcomes in patients with operable breast, prostate, and colorectal cancers.<br /><br />
															</td>
														</tr>
														<tr>
															<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786;">
															<a style="text-decoration: none; color: #318786;" href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599ac65579570c2fbf91be31c83cbd51ed55ff854bc6ec5fdca9c5e3647b45c67ef4c" title=" Exercise Alterations of the Host-Tumor Interaction"  >Read the Full Story &#187;</a>
															</td>
														</tr>
													</tbody>
												</table>
												</td>
											</tr>
										</tbody>
									</table>
									</td>
								</tr>
							</tbody>
						</table>
						</td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
									    </tr>
									    <tr>
									    	<td width="618"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table cellspacing="0" cellpadding="0" class="dashedBorder">
	<tbody>
		<tr>
			<td width="618" align="center" style="border-top: 1px solid #ffffff; border-bottom: 2px solid #ffffff; padding: 12px 0px; background: #d2e8e2 none repeat scroll 0% 0%;">
			<table cellspacing="0" cellpadding="0">
				<tbody>
					<tr>
						<td align="center" style="font-family: arial,sans-serif; font-size: 16px; font-weight: bold; color: #6a6a6a; line-height: 30px ! important;">
						<a   href="http://click.broadcastemail.asco.org/?qs=4c58e248b77599ace097096a23d7863a8605a36eb881e62ef7990f42db26a770a691217dac4fd4e7" style="text-decoration: none; color: #318786;" title="https://am.asco.org/daily-news"><i>ASCO Daily News</i> Home</a><a href="http://click.broadcastemail.asco.org/?qs=0b58940c530697c2f65f62430342b66707f015b4e8fb72552386b03e24cbba068f12813cc7e61ee469d65e0ba4b3ac64" title="ASCO Daily News Home"  ></a> | <a href="http://click.broadcastemail.asco.org/?qs=0b58940c530697c2740b8b94ef0225b6b9f0994fa3be709c4dcc03685c0d03b88fc5e081b5d5eccc26905e1922d3eeea" style="text-decoration: none; color: #318786;" title="Session coverage"  >Session Coverage</a> | <a href="http://click.broadcastemail.asco.org/?qs=0b58940c530697c263e50fd9fac07b10dcf891a19ee1a1787e895afe335fac53f09e769c5f17cfc1bb6ea55821062c14" style="text-decoration: none; color: #318786;" title="Expert editorials"  >Expert Editorials</a>
						</td>
					</tr>
					<tr>
						<td align="center" style="font-family: arial,sans-serif; font-size: 16px; font-weight: bold; color: #6a6a6a; line-height: 30px ! important;">
						<a href="http://click.broadcastemail.asco.org/?qs=0b58940c530697c2cfb3843d7c1ab8cd1d6af3d83a94583be14b5e99bae881cf37b6ad0d9debae3fab9f4fc12bd23b66" style="text-decoration: none; color: #318786;" title="Grants and Awards"  >Grants and Awards</a> | <a href="http://click.broadcastemail.asco.org/?qs=0b58940c530697c23a114c89fd00f0a17d392f83f82b9046722eb016d6e2d367c5fc767c8d8d13e6c2000f828cbdc463" style="text-decoration: none; color: #318786;" title="am.asco.org"  >am.asco.org</a>
						</td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
									    </tr>
									    <tr>
									    	<td width="618"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table cellpadding="0" cellspacing="0" class="dashedBorder">
	<tbody>
		<tr>
			<td width="618" align="center" style="padding: 12px 0px; background: #efefef;">
			<table cellpadding="0" cellspacing="0">
				<tbody>
					<tr>
						<td style="font-family: arial, sans-serif; font-size: 16px; color: #575757; padding-right: 10px;">Connect with us:</td>
						<td style="padding-right: 10px;"><a href="http://click.broadcastemail.asco.org/?qs=0b58940c530697c23077f4909b309bbd5ea4fa54b17e025bdafe67ea0f169b0b43c76a28d09a489d709f5c9d658edccd" title="Twitter"  ><img src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/eDigest_11.jpg" style="display: block; border: 0px; width: 32px; height: 32px; margin: 0px;" width="32" height="32" /></a></td>
						<td style="padding-right: 10px;"><a href="http://click.broadcastemail.asco.org/?qs=0b58940c530697c282b466309732b3032cc9b6d8fc4ab35f8065d2619354ac3fa1f99f4725ead59d32cc4f968e454400" title="Facebook"  ><img src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/eDigest_13.jpg" style="display: block; border: 0px; width: 32px; height: 32px; margin: 0px;" width="32" height="32" /></a></td>
						<td style="padding-right: 10px;"><a href="http://click.broadcastemail.asco.org/?qs=0b58940c530697c2927b02840fac31b85fdf522cf7ba5df941842a7a645b7e40f603cf02263744eadd92496d05086a74" title="Linkedin"  ><img src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/eDigest_15.jpg" style="display: block; border: 0px; width: 32px; height: 32px; margin: 0px;" width="32" height="32" /></a></td>
						<td style="padding-right: 20px;"></td>
						<td style="font-family: arial, sans-serif; font-size: 16px; color: #575757; padding-right: 10px;">
						<a href="http://click.broadcastemail.asco.org/?qs=0b58940c530697c258e426f1dc7df45313af29a07ca8d7ecd3b82ec24ef42b211a866730327b74a8" style="text-decoration: none; color: #318786;">Forward to a Colleague</a>
						</td>
						<td><a href="http://click.broadcastemail.asco.org/?qs=0b58940c530697c258e426f1dc7df45313af29a07ca8d7ecd3b82ec24ef42b211a866730327b74a8"><img src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/eDigest_19.jpg" alt="Email" style="display: block; border: 0px;" /></a></td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
									    </tr>
    								</table>
    							</td>
    							<td width="16" style="font-size: 1px; min-width: 16px;">&nbsp;</td>
    							<td width="160" valign="top">
    								<table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><div align="center"><a href="http://click.broadcastemail.asco.org/?qs=0b58940c530697c28f8f0d0e174b4199914ac70073f5c3931dd86b786f6ce51f5e82302fd8781bf5" title="Sidebar Ad"  ><img width="160" height="600" border="0" alt="1-alectinib_alex_unbranded_banner_160x600" title="1-alectinib_alex_unbranded_banner_160x600" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/1-alectinib_alex_unbranded_banner_160x600.gif" style="width: 160px; height: 600px; border-color: #000000; margin: 0px;" /></a>
<br />Advertisement</div></td></tr></table></td></tr></table>
    							</td>
    						</tr>
    					</table>
    				</td>
    			</tr>
    		</table>
    	</td>
    </tr>
    <tr>
    	<td class="disclaimer" width="826" align="center">
    		<table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><div align="center"><a   title="ASCO Connection" href="http://click.broadcastemail.asco.org/?qs=babd0227a5dd2adb105115a7403baec99509ea296d9aab5c3aef127bd3c3f5f19d8b8e565df5ac9a"><img width="728" height="90" border="0" style="width: 728px; height: 90px; border-color: #000000; margin: 0px;" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/AC-web-ad-728x90_2015-05-26.png" title="AC-web-ad-728x90_2015-05-26" alt="AC-web-ad-728x90_2015-05-26" /></a><br />Advertisement</div></td></tr></table></td></tr></table>
    	</td>
    </tr>
</table>
                        </td>
                    </tr>
                    <tr>
                      
                                            </tr>
                                        </table>
                                    </td>
                                </tr>
                            </table>
                        </td>
                    </tr>
                </table>
            </td>
        </tr>
    </table>

    <!-- Exact Target tracking code -->
    <img src="http://click.broadcastemail.asco.org/open.aspx?ffcb10-fe5a1776746705757c12-fdc61574706c037c7112727664-fe6015707d670579731c-fe6415787165027c7710-fe271d7877640475761579-ff5e10747c" width="1" height="1">

</body>
 <!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<title></title>
</head><body style="background: #d8d8d8;font-family:Arial, Helvetica, sans-serif; font-size:1em;">
<body>


<div width="850" style="margin-left: auto; margin-right: auto; width: 850px; text-align: left;">

You are receiving this email because you have an existing relationship
with ASCO.&nbsp; Visit your personalized <a
href="http://click.broadcastemail.asco.org/?qs=babd0227a5dd2adb8df0bab3b3362d5973fd3c3c535651d26ead91306e1d560353b20601af56f409"
target="_blank">Preference Center</a> to unsubscribe or to select
your preferences for receiving ASCO promotional email.&nbsp; Please do
not reply to this email.&nbsp; <br>
This email was sent by: American Society of Clinical Oncology<br>
2318 Mill Road, Suite 800 Alexandria, VA,
22314, USA<br></div>
</body>
</body>
</html>

--gsbCJixYb5BE=_?:--

